A股異動 | 眾源新材(603527.SH)觸及漲停 佈局半固態動力電池產業化項目
格隆匯2月18日丨眾源新材(603527.SH)急升觸及漲停,現報7.88元,總市值19.21億元。
眾源新材2月9日晚間披露,因公司長期戰略規劃及經營發展需要,公司擬以全資子公司安徽眾源新材投資有限公司出資1000萬元參與安徽安瓦新能源科技有限公司的增資擴股,同時還有其他多家公司參與本次增資擴股。增資擴股完成後,安瓦新能源註冊資本增加至8282.61萬元,眾源投資持有其1.11%股權。據悉,2020年12月7日,安瓦新能源半固態動力電池產業化項目在蕪湖經開區管委會簽約。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.